Aktie CHINA BIOLOGIC PRODUCTS INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen China Biologic Products Inc Nasdaq

Aktien

US16938C1062

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Snapshot: The Resurgence Of Take-private Transactions In Asia
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from S&P Global BMI Index
China Biologic Products Holdings, Inc.(NasdaqGM:CBPO) dropped from FTSE All-World Index
China Biologic Products : Announces Completion of Going Private Transaction
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from NASDAQ Biotechnology Index
China Biologic Products Holdings, Inc.(NasdaqGM:) dropped from NASDAQ Composite Index
Centurium Capital Management Ltd., CITIC Capital Partners Management Ltd., Parfield International Ltd., V-Sciences Investments Pte Ltd, Hillhouse Capital Management, Ltd. and Joseph Chow, Chairman and Chief Executive Officer of China Biologic Products Holdings, Inc. completed the acquisition of remaining 31.16% stake in China Biologic Products Holdings, Inc..
China Biologic Products : CBPO 4Q20 Presentation Material
China Biologic Products: Q4 Earnings Snapshot
China Biologic Products Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
China Biologic Products : Q4 Profit, Revenue Rise from Year Ago
China Biologic Products : Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
China Biologic Products : Announces Shareholders' Approval of Merger Agreement
China Biologic Products : Announces Extraordinary General Meeting of Shareholders
China Biologic Products Holdings, Inc. Announces Resignation of Yue’e Zhang from the Board of Directors
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 9.72% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 2% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.
CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.
China Biologic Products : CBPO 3Q20 Presentation Material
China Biologic Products Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DU6G Aktie
  4. Aktie
  5. Nachrichten China Biologic Products Inc
  6. Andere Sprachen